Company · CIK 0001551152 · SIC 2834 — Pharmaceutical Preparations · NYSE
AbbVie Inc. · ABBV
Insider activity reported against this company. All insider holders · Files at: RETA. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 SForm 4 → | Aug 18, 5:00 pm EDT | Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | 32,710 | $250.00 | $8,177,500 | 74,430 | −30.5% | |
| Aug 14, 2026 MForm 4 → | Aug 18, 5:00 pm EDT | Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | 32,710 | $79.02 | $2,584,744 | 107,140 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 MForm 4 → | Aug 18, 5:00 pm EDT | Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | 32,710 | — | — | 0 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 5:00 pm EDT | Edward J RappDirector | 134 | $251.64 | $33,720 | 29,236 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 5:00 pm EDT | Susan E QuagginDirector | 62 | $251.64 | $15,602 | 853 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.